Endothelial cells are involved in important pathological situations. They could be the target for infectious processes as for example in Cowdriosis, an important disease in cattle due to the rickettsia Cowdria ruminantium prevalent in the south of the Sahara. They are also connected to angiogenic processes related to tumor invasion.
Introduction
Endothelial cells play a crucial role in a number of pathological conditions and in their regulation. Blood coagulation, inflammation, immune response, infections and tumoral invasion processes are of course of major concern in this respect. Angiogenesis mechanisms are particularly relevant to the understanding of these different situations (Fajardo, 1989; Jaffe, 1987; Folkman and Shing, 1992) . Undoubtly also, cytokines play an important role in the regulation of pathophysiological responses of endothelial cells and in their overall behaviour.
We have been interested in two important pathological situations for which better knowledge of endothelial properties could permit the identification of therapeutical solutions: 1. The first situation concerns a deadly cattle disease (Cowdriosis or Heartwater) prevalent in the south of the Sahara and which is caused by the multiplication of an obligate intracellular bacteria, the rickketsia Cowdria ruminantium, for which the final cellular targets are endothelial cells from the brain capillary vessels (Totté, Jongejan et al., 1994) . 2. The second situation concerns Kaposi (KS), an angioproliferative disease prevalent in AIDS patients and characterized by the dissemination of vascular lesions on the skin or mucosal tissues. Simonart et al., 1996) .
Migration and proliferation of endothelial cells, being relevant to the understanding of both conditions, we have first studied the effect of components of the cytokine network on the expression of the matrix metalloproteinases (MMPases), since these enzymatic activities are related to vascular permeability and cellular mobility (Coulombe et al., 1989) . We have used in this study therefore, endothelial cells of bovine origin routinely used to cultivate Cowdria ruminantium (a bovine umbilical endothelial cell line -BUEC) and of human origin, primarily the human spindle like cells we have isolated from AIDS related-KS biopsies, comparing them to primary cultures of human umbilical vein endothelial cells (HUVEC) and to SV40 T antigen transfected HUVEC (pSC1 cells) or to 1/2 C10 (HUVEC-Human Osteosarcoma cell line hybrid).
The two main related questions adressed here were the following: -Could we find conditions enabling in vitro maintanance of spindle like cells obtained from Kaposi sarcoma that we characterized here as of endothelial origin, in order to select potential treatment (including using cytokines) to reduce growth and invasiveness of the KS cells? -Could we find conditions permiting maintenance of endothelial cell cultures in spinner bioreactors for the extended period of time (more than two weeks) necessary to produce enough of Cowdria ruminantium variants to be tested as potential attenuated vaccine which was up to now unavailable?
The approach we took to answer these questions was to identify and characterize factors which, while inhibiting cell mobility related to the invasive process, would be a potential inhibitor for KS spreading, and would, by increasing their adhesion on microcarriers, limit their sensitivity of mechanical stress during maintenance in bioreactor for Cowdria ruminantium production.
Material and methods

Cells, culture conditions and procedure for infection with Cowdria ruminantium
Routinely the cells were passaged by trypsinization with 0.05% trypsin and 0.02% EDTA in PBS. Cell number was determined in triplicate by Trypan blue exclusion with an hemacytometer. Infection with Cowdria ruminantium: the Senegal stock of the rickettsia used was originally obtained from Dr F. Jongejan from Utrecht University, and infection in endothelial cells was operated and revealed as previously described (Totté, Blankaert et al., 1993) .
HUVEC cells.
(Primary human umbilical vein endothelial cells) were isolated from full-term unbilical cord vein treated as described by Gimborne et al. (1974) . Cells isolated by collagenase treatment of 7 umbilical cords were pooled and grown on gelatincoated disks in Minimum Essential Medium containing D-Val, with 20% decomplemented foetal calf serum, 100 g/ml endothelial growth factor, and Penicillin (100 U/ml) and streptomycin (100 g/ml). Incubation was operated at 37 C in humid atmosphere at 5% CO 2 /95% O 2 .
Kaposi sarcoma cells. KS cell cultures were established as previously described , and as it will be reported more extensively elsewhere. In brief, biopsies of KS lesions minced into small pieces were treated for 90 minutes at 37 C with Trypsin (0.3% -1% EDTA) or collagenase (1 mg/ml from Clostridium histolyticum). After centrifugation the cells were washed and cultivated in the same medium as used for HUVEC and grown similarly with 20% decomplemented foetal calf serum and 1% non essential amino acids. pSV1 cells. HUVEC cells transfected with T antigen from SV40 (Lassale et al., 1992) were kindly supplied to us by Dr V. Fafeur from Pasteur Institute (Lille). Those cells were grown in RPMI 1640 medium with 10% Foetal calf serum and the usual proportion of antibiotics.
1/2 C10 cells. HUVEC -Human Osteosarcoma cell line was provided by the group of Prof. Kattinger (Vienna, Austria).
BUEC cells.
(Bovine Umbilical endothelial cells) were originally obtained from Dr F. Jongejan from Utrecht University, The Netherlands. They were grown in DMEM (GIBCO Life Technologies) in presence of 10% decomplemented Foetal Calf Serum, and the usual amount of antibiotics, 1% essential amino acids and 1% glutamine.
Microcarriers used. Routinely Cytodex 1, 2 and 3 are used, but in some experiments Cytocell or Cultispher S microcarriers have been tested also. The microcarriers obtained in a dry state were treated in the conditions recommended by the producer and routinely washed twice with prewarmed culture medium before use. Spinner cultures are made in CO 2 incubators under agitation of 30 rpm.
Conditioned medium and its "activation". Cultures of HUVEC in tissue culture flasks of 80 cm 2 were maintained for 48 h in fresh medium which was then harvested and kept as "conditioned medium" (CM). Its activation resulted from acidification until pH2 with 10 M HCl for 1 h at 4 C, after which neutralization was quickly operated with 10 M NaOH.
Cytokines and other factors used for cell treatment
TNF. Human recombinant Tumor Necrosis Factor (TNF). TNF at 10 8 cytotoxic units/mg was received from Dr M. Bochaus (Hoffman LaRoche, Basel, Switserland).
PMA. 4 Beta-Phorbol-12-Myristate-13 Acetate (PMA) was from Sigma (St Louis; Mo, USA).
TGF. Human natural TGF obtained from Promega
is diluted at 30 g/ml in normal medium without serum for investigating its effect between 0.25 and 1 ng/ml. During treatment, medium was changed every day and collected after 24 and 48 h incubation without serum before testing MMPases by Zymography.
Antibodies against TGF. Dehydrated Monoclonals against TGF 1, 2 and 3 at 300 pg TGF or rabbit polyclonals used at a dilution of 1/200 were also from Promega.
Gelatin zymography
The gel electrophoresis analysis of Metalloproteinases (MMPases) were performed by the method of Heusen and Dowdle (1980) adapted as previously described (Marique et al., 1991) . 10% gel electrophoresis was operated at 4 C at 20 mA for 3 hours. After soaking in 2.5% Triton X100 to remove SDS, gels were incubated overnight in a buffer containing 5 mM CaCl 2 , 0.02% Sodium Azide, and 50 mM Tris pH 7.5. Gels were then stained in 0.5% Coomassie brilliant blue in acetic acidisopropanol-water (1:3:6) and photographed on a lightbox. The analysis of conditioned medium requires to incubate cells without serum for at least 24-48 h before testing since serum contains MMPases.
Immunofluorescence techniques
Cells (HUVEC, BUEC or Spindle like cells) were treated first with Factor VIII mouse antibodies (1/150) and second by fluorescein conjugated immunoglobulins (DAKO).
Results
Expression of factor VIII in the cells used
All the cells used in the present study -BUEC, HUVEC, KS ( Figure 1A , B, C) and 1/2 C 10 ( Figure  1D ) and psVI (data not shown) expressed Factor VIII when tested with mouse antibodies detected by fluorescein conjugated immunoglobulins. The expression is rather intense and in fact less diffuse in BUEC and KS cells, than in HUVEC and in the derived 1/2 C cells. This indicated that, at least at the early passage used here, KS cells were originating from endothelial related tissues. Knowing the relative difficulties to grow endothelial cells in vitro, and in order to establish conditions that could hopefully stabilize their maintenace in culture, we have tested the effect of cytokines and other factors from which we could expect a possitive effect due to their role in the expression of Metalloproteinases (MMPases) involved in the mobility and invasiveness of endothelial cells.
Effect of PMA and TNF on MMPases expression in BUEC cells
Zymography revealed in BUEC cells (Figure 2A and B) the activity of different MMPases. We showed here that the relative expression of the 92 kD MMPase relative to the 72 kD enzyme, is much more increased by PMA. (Maximal activity is observed at 10 nM). TNF also increased relatively more efficiently the expression of the 92 kD MMPase versus the 72kD enzyme (Optimal activity is obtained between 5 and 10 ng/ml).
The same approach has been taken to analyze MMPases expression in KS cells ( Figure 3A and B) , and the same conclusions can be drawn. PMA increases relatively 92 kD MMpase (maximal activity reached at 8 nM) -and TNF also. (The activity is clearly detected at 5 ng/ml). As it is known that the level of expression of the 92 kD MMPase is related to cell mobility, as observed for example in metastatic processes, zymography was used to select conditions in which cell movement may be potentially reduced.
Effect of conditioned medium and TGF on MMPases expression in BUEC and KS cells, and on their growth in vitro
Zymographic analysis of the expression by BUEC or KS cells under conditioned medium treatment (respectively Figure 4A and Figure 5A ) or TGF action (Figure 4B and 5B) revealed that 92 kD MMPase expression is clearly reduced by both treatments. In parallel experiments (data not shown) we have observed that TGF , in a dose dependent manner, reduced BUEC cell growth. More than 40% inhibition was obtained at 1 ng/ml, a similar effect being observed with conditioned medium. We tested, therefore using monoclonal antibodies against TGF , if the effect obtained with conditioned medium on the growth of the endothelial cells is due to this factor. Our results showed (Figure 6 ) that it is indeed the case both in BUEC and KS cells grown in Petri dishes. Conditioned medium, before acid activation already caused a partial inhibi- 
Colonization of microcarriers by BUEC and KS cells and its inhibition by activated conditioned medium
We compared different microcarriers (Cytodex 1, 2 and 3, Cytocell, and Cultispher S were used). Cytodex were more efficiently colonized than Cytocell and Cultispher (data not shown) and Figure 7 indicates that BUEC cells spread better on Cytodex 3 than on Cytodex 2, after seeding them on a confluent monolayer culture. Therefore, Cytodex 3 was selected as microcarrier for subsequent studies. Using Cytodex 3, we showed that in 48 hours, the microcarriers have been invaded by KS or BUEC cells (up to 30-35% saturation) when seeded on a confluent monolayer, while conditioned medium, especially after activation, is readily inhibiting the colonization (Figure 8 ). Therefore cell motility is inhibited in parallel to the reduction of the expression of the 92 kD MMPase.
Maintenance of BUEC cells in "Spinner" flasks
In order to produce in mass the Cowdria ruminantium stock that we intend to test as an attenuated vaccine, we followed first the behavior of Cytodex 3 microcarriers colonized by BUEC cells in "spinner" flasks in two conditions -with normal medium or with activated conditioned medium. We observed (Figure 9 ) that cells seeded on confluent BUEC monolayers, when incubated in normal culture medium, detached readily from the microcarriers, and after a week of incubation, all cells died. On the contrary, when incubated with activated conditioned medium, most of the cells were maintained in healthy conditions for the long period of time required for Cowdria ruminantium development.
We therefore checked if Cowdria ruminantium production could be operated in presence of TGF .
Infection of BUEC cells by Cowdria ruminantium in presence of TGF
Cowdria ruminantium develop normally in BUEC cells in the presence of TGF (1 ng/ml) as shown in Figure   10 . Vacuoles which are hosting Cowdria ruminantium are formed similarly in the presence or absence of TGF after the 9 days necessary for the main part of the rickettsia maturation process. Appropriate conditions for an efficient vaccine production can therefore be now foreseen.
Discussion
Given our double goal in this study to characterize Kaposi spindle like cells in order to check potential inhibitors for treatment of the corresponding disease, and to define maintenance conditions for Cowdria ruminantium infected BUEC cells in order to propose an appropriate vaccine production process -the present approach has been quite rewarding. Kaposi Sarcoma (KS) cells that we isolated from AIDS patients biopsies, expressed Factor VIII, indicating their endothelial origin, and as BUEC, expressed 92 kD MMPase at high level when stimulated either by PMA, TNF, or by both agents as indicated previously . We showed here that TGF and activated conditioned medium reduced the expression of 92 kD MMPase, appearing therefore as a potential cell mobility inhibitor of interest for KS treatment. It appeared also for the same reason as a valuable maintenance factor for Cowdriosis vaccine production. Therefore, the scale up of endothelial cell production process, recently proposed by S. Duvar et al. (1996) , could be adapted for infection with Cowdria ruminantium. (Totté, Blankaert et al., 1994) .
The first part of our conclusions should now be further investigated by appropriate in vivo tests before clinical studies, while the second part is currently under investigation in our laboratory, in parallel to a related metabolic engineering approach for which we have briefly described preliminary conditions (C. Alloin et al., 1996) .
